Check-Cap submits IDE application for C-Scan

By staff writers

October 9, 2018 -- Colon capsule developer Check-Cap has submitted an investigational device exemption (IDE) application to the U.S. Food and Drug Administration (FDA) for its C-Scan system.

The vendor said it plans to launch a pilot study in the U.S. in the fourth quarter if the FDA approves the IDE. C-Scan is an ingestible capsule-based system aimed at enabling preparation-free colorectal cancer screening, according to the firm.

Copyright © 2018

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking